Thursday, December 27, 2018 10:38:24 AM
In the case of B, since there would be nothing comparable that can possibly PREVENT the occurrence of OM - which remember, would be a VERY costly side effect for an insurance company - I suspect that insurances would adopt paying for this quickly in off label uses.
As for the FDA letting docs prescribe off-label whenever they want: Remember, approved meds have already gone through extensive safety testing to get where they are. If something comes up after approval, a drug can then be pulled - or not. An example of not, even in what appears to be an extreme case is some antipsychotics used in psychiatry. It's been discovered over the years that a rare side effect in the elderly can be sudden death (due to cardiac issues). The FDA has not pulled these drugs because they are so beneficial in many populations, but rather has added a "black box warning" to them, specifically warning of this side effect in this population. But, even that doesn't mean a doc is prohibited from prescribing these drugs in the elderly, and many still do. It just means that in addition to informing the patient/family that this is an off-label use, the doc has to also inform them of the black box warning, so they can make an informed consent decision.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM